These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 10961715)
1. In vivo selectivity of nonsteroidal antiinflammatory drugs and gastrointestinal ulcers in rats. Laudanno OM; Cesolari JA; Esnarriaga J; San Miguel P; Bedini OA Dig Dis Sci; 2000 Jul; 45(7):1359-65. PubMed ID: 10961715 [TBL] [Abstract][Full Text] [Related]
2. [In vivo selectivity of nonsteroidal anti-inflammatory drugs on COX-1-COX-2 and gastrointestinal ulcers, in rats]. Laudanno OM; Cesolari JA; Esnarriaga J; Flaherty P; Vada J; Guastalli G; San Miguel P; Bedini OA Acta Gastroenterol Latinoam; 1998; 28(3):249-55. PubMed ID: 9773153 [TBL] [Abstract][Full Text] [Related]
3. Interaction between NSAIDs and steroid in rat stomach: safety of nimesulide as a preferential COX-2 inhibitor in the stomach. Kataoka H; Horie Y; Koyama R; Nakatsugi S; Furukawa M Dig Dis Sci; 2000 Jul; 45(7):1366-75. PubMed ID: 10961716 [TBL] [Abstract][Full Text] [Related]
4. Effects of cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal antiinflammatory drugs on mucosal ulcerogenic and healing responses of the stomach. Ukawa H; Yamakuni H; Kato S; Takeuchi K Dig Dis Sci; 1998 Sep; 43(9):2003-11. PubMed ID: 9753266 [TBL] [Abstract][Full Text] [Related]
5. NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. Wallace JL; McKnight W; Reuter BK; Vergnolle N Gastroenterology; 2000 Sep; 119(3):706-14. PubMed ID: 10982765 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Jones MK; Wang H; Peskar BM; Levin E; Itani RM; Sarfeh IJ; Tarnawski AS Nat Med; 1999 Dec; 5(12):1418-23. PubMed ID: 10581086 [TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Cryer B; Feldman M Am J Med; 1998 May; 104(5):413-21. PubMed ID: 9626023 [TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs: investigation using human peripheral monocytes. Kato M; Nishida S; Kitasato H; Sakata N; Kawai S J Pharm Pharmacol; 2001 Dec; 53(12):1679-85. PubMed ID: 11804398 [TBL] [Abstract][Full Text] [Related]
10. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers. Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1. Ogino K; Hatanaka K; Kawamura M; Katori M; Harada Y Pharmacology; 1997 Jul; 55(1):44-53. PubMed ID: 9309800 [TBL] [Abstract][Full Text] [Related]
12. Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs. Giuliano F; Warner TD Br J Pharmacol; 1999 Apr; 126(8):1824-30. PubMed ID: 10372826 [TBL] [Abstract][Full Text] [Related]
13. Meloxicam inhibits prostaglandin E(2) generation via cyclooxygenase 2 in the inflammatory site but not that via cyclooxygenase 1 in the stomach. Ogino K; Hatanaka K; Kawamura M; Ohno T; Harada Y Pharmacology; 2000 Nov; 61(4):244-50. PubMed ID: 11093076 [TBL] [Abstract][Full Text] [Related]
14. Chronic gastric ulcer healing in rats subjected to selective and non-selective cyclooxygenase-2 inhibitors. Berenguer B; Alarcón de la Lastra C; Moreno FJ; Martín MJ Eur J Pharmacol; 2002 May; 442(1-2):125-35. PubMed ID: 12020690 [TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. Silverstein FE; Faich G; Goldstein JL; Simon LS; Pincus T; Whelton A; Makuch R; Eisen G; Agrawal NM; Stenson WF; Burr AM; Zhao WW; Kent JD; Lefkowith JB; Verburg KM; Geis GS JAMA; 2000 Sep; 284(10):1247-55. PubMed ID: 10979111 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays. Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818 [TBL] [Abstract][Full Text] [Related]
17. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894 [TBL] [Abstract][Full Text] [Related]
18. Determination of expression of cyclooxygenase-1 and -2 isozymes in canine tissues and their differential sensitivity to nonsteroidal anti-inflammatory drugs. Wilson JE; Chandrasekharan NV; Westover KD; Eager KB; Simmons DL Am J Vet Res; 2004 Jun; 65(6):810-8. PubMed ID: 15198222 [TBL] [Abstract][Full Text] [Related]
19. [Preferential COX-2 inhibition: its clinical relevance for gastrointestinal non-steroidal anti-inflammatory rheumatic drug toxicity]. Dammann HG Z Gastroenterol; 1999 Jan; 37(1):45-58. PubMed ID: 10091284 [TBL] [Abstract][Full Text] [Related]
20. Effects of food intake and oxidative stress on intestinal lesions caused by meloxicam and piroxicam in rats. Villegas I; Alarcón de la Lastra C; La Casa C; Motilva V; Martín MJ Eur J Pharmacol; 2001 Feb; 414(1):79-86. PubMed ID: 11230998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]